Equity Capital Markets

Lexicon Pharmaceuticals, Inc.

01/26
|
$94.5 Million
t
Piper Sandler served as bookrunner for Lexicon Pharmaceuticals, Inc. on its CMFO and Pipe
Sub-Type
CMFO
Sector
Healthcare
Sub-Sector
Biopharma

Related Transactions

All Transactions
f
OKYO Pharma
Confidentially Marketed Follow-On Offering
Financial Advisor
s
Nektar Therapeutics
Follow-On Offering
Active Bookrunner
$94.5 Million
t
Lexicon Pharmaceuticals, Inc.
CMFO and PIPE
Active Bookrunner
$250.0 Million
d
Rithm Capital
Preferred Stock
Joint Bookrunner
o
BioAge Labs
Follow-On Offering
Active Bookrunner
s
Arrowhead Pharmaceuticals, Inc.
Follow-On Offering
Passive Bookrunner
b
Monte Rosa Therapeutics
Follow-On Offering
Active Bookrunner
r
Bright Minds Biosciences
Follow-On Offering
Active Bookrunner
e
Praxis Precision Medicines
Confidentially Marketed Follow-On Offering
Left Bookrunner
e
Crinetics Pharmaceuticals
Follow-On Offering
Active Bookrunner
$2.5 Billion
h
Annaly Capital Management
ATM Program Common Stock
Sole Placement Agent
$7.3 Billion
s
Medline Industries
Initial Public Offering
Passive Bookrunner
w
Tenaya Therapeutics
Confidentially Marketed Follow-On Offering
Active Bookrunner
s
Miami International Holdings, Inc.
Follow-On Offering
Active Bookrunner
$75.0 Million
w
Protara Therapeutics
Confidentially Marketed Follow-On Offering
Active Bookrunner
$172.5 Million
e
Capricor Therapeutics
Confidentially Marketed Follow-On Offering
Left Bookrunner

© 2026 Piper Sandler Companies. Since 1895. All rights reserved.